Loading clinical trials...

Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO) | Clinical Trials | Clareo Health

UNKNOWNPhase 4NCT05682859

Treatment of Chronic Hand Eczema With Oral Roflumilast (HERO)

This study is a multicentre, double-blinded, randomized, placebo-controlled, clinical trial with open-label extension. The purpose and aim of this study is to investigate the efficacy and safety of r...

Lead sponsor: Jacob Pontoppidan Thyssen•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Contacts

Jacob P Thyssen, Professor, MD, DMSc

CONTACT

38636173 jacob.pontoppidan.thyssen@regionh.dk

Maria O Christensen, MD

CONTACT

26171989 maria.oberlaender.christensen@regionh.dk

Related studies

COMPLETEDPhase 2

Efficacy, Safety, and Tolerability of Abrocitinib in Subjects With Moderate to Severe Chronic Hand Eczema Refractory to Corticosteroid Therapy

NCT06283550 · Chronic Hand Eczema

COMPLETEDPhase 3

A 24 Week Trial to Compare the Efficacy and Safety of Delgocitinib Cream 20 mg/g Twice-daily With Alitretinoin Capsules Once-daily in Adult Participants With Severe Chronic Hand Eczema

NCT05259722 · Chronic Hand Eczema

COMPLETEDPhase 3

Efficacy and Safety of Delgocitinib Cream in Adults With Moderate to Severe Chronic Hand Eczema (DELTA 2)

NCT04872101 · Chronic Hand Eczema

WITHDRAWN

Prospective Real-World Clinical Investigation on Dexyane Med® in Adults With Chronic Hand Eczema

NCT05545215 · Chronic Hand Eczema

WITHDRAWNPhase 3

Topical Ruxolitinib Evaluation in Chronic Hand Eczema Study 2

NCT05233410 · Chronic Hand Eczema (CHE)

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 18, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE4

Enrollment40

Start dateSep 2023

Last updatedNov 18, 2023

Condition

Chronic Hand Eczema

Locations shown

Department of dermatology and veneorology, Bispebjerg Hospital

Copenhagen

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 18, 2023Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions